Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Clinical trial NCT01933815 · SUSPENDED
Trial details
- NCT number
- NCT01933815
- Sponsor
- Cortice Biosciences, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2024-11-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.